您当前的位置：
首页 >
文章列表页 >
EGFR抑制剂吉非替尼对肝癌细胞增殖和凋亡的影响
更新时间：2026-01-09

    • EGFR抑制剂吉非替尼对肝癌细胞增殖和凋亡的影响

    • Journal of Army Medical University   Vol. 28, Issue 2, Pages: 125-128(2006)
    • CLC： R73053;R735.7;R979.1

    • Published：2006

    移动端阅览

  • 何怡, 王东, 张沁宏, et al. EGFR抑制剂吉非替尼对肝癌细胞增殖和凋亡的影响[J]. Journal of Army Medical University, 2006, 28(2): 125-128. DOI：

  •  
  •  
icon
试读结束，您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束，您可以通过登录账户，到个人中心，购买VIP会员阅读全文。
已是VIP会员？
去登录 >

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Progress and prospect of epidermal growth factor receptor tyrosine kinase inhibitor in treatment of non-small cell lung cancer
Predictive value of clinical parameters in responses to epidermal growth factor-tyrosine kinase inhibitors as first-line therapy for stage Ⅳ non-small cell lung cancer
264例肺腺癌患者EGFR基因突变及TKI类药物临床疗效分析
非小细胞肺癌ERCC1 C118T多态性与EGFR突变的相关性
EGFR信号通路调控结肠癌Caco-2细胞侵袭转移的分子机制

Related Author

Guoming WU
Hanshui JIANG
Jianguo SUN
Yongxin YU
Qiao YANG
Feng LI
Guangkuo ZHU
Zihan XU

Related Institution

Department of Respiratory and Critical Care Medicine, Shulan (Hangzhou) Hospital
Cancer Institute, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
0